WHO ICTRP trial

A randomized comparison of clinical outcomes between everolimus-eluting…

KCT0002900 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0002900
Public title A randomized comparison of clinical outcomes between everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent in long coronary lesions
Scientific title A randomized comparison of clinical outcomes between everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent in long coronary lesions
Primary sponsor Yonsei University Health System, Severance Hospital
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Not applicable
Countries Korea, Republic of
Conditions Diseases of the circulatory system
Interventions Medical Device : •Device: PCI with Absorb everolimus-eluting bioresorbable vascular scaffold Patients allocated to this arm will undergone PCI with Absorb everolimus-eluting bioresorbable vascular scaffold. It will be allowed to used…
Registration date May 29, 2018
Target size 950
Secondary IDs NCT02796157
Registry page cris.nih.go.kr

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations